Success Metrics

Clinical Success Rate
87.2%

Based on 156 completed trials

Completion Rate
87%(156/179)
Active Trials
63(20%)
Results Posted
3%(4 trials)
Terminated
23(7%)

Phase Distribution

Ph phase_4
10
3%
Ph phase_2
7
2%
Ph early_phase_1
1
0%
Ph phase_3
8
3%
Ph phase_1
4
1%
Ph not_applicable
162
51%

Phase Distribution

5

Early Stage

7

Mid Stage

18

Late Stage

Phase Distribution192 total trials
Early Phase 1First-in-human
1(0.5%)
Phase 1Safety & dosage
4(2.1%)
Phase 2Efficacy & side effects
7(3.6%)
Phase 3Large-scale testing
8(4.2%)
Phase 4Post-market surveillance
10(5.2%)
N/ANon-phased studies
162(84.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.0%

156 of 188 finished

Non-Completion Rate

17.0%

32 ended early

Currently Active

63

trials recruiting

Total Trials

320

all time

Status Distribution
Active(77)
Completed(156)
Terminated(32)
Other(55)

Detailed Status

Completed156
unknown54
Recruiting48
Terminated23
Active, not recruiting15
Not yet recruiting11

Development Timeline

Analytics

Development Status

Total Trials
320
Active
63
Success Rate
87.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.5%)
Phase 14 (2.1%)
Phase 27 (3.6%)
Phase 38 (4.2%)
Phase 410 (5.2%)
N/A162 (84.4%)

Trials by Status

enrolling_by_invitation31%
active_not_recruiting155%
completed15649%
suspended10%
unknown5417%
recruiting4815%
withdrawn93%
not_yet_recruiting113%
terminated237%

Recent Activity

Clinical Trials (320)

Showing 20 of 320 trialsScroll for more
NCT07705178Not Applicable

More Than Just X-Rays - Imaging of Chemotherapy-induced Morphological and Functional Cardiovascular and Lung Changes After Childhood ALL and Other Cancers - a Monocentric Late Effects Study (MaximALL)

Recruiting
NCT07692815Not Applicable

Sex-difference in Response to Resistance Exercise and Training

Enrolling By Invitation
NCT06996249

Prospective Data Collection Initiative on Thoracic Malignancies

Recruiting
NCT07280091

Study of Skin and Gut Microbiome in a Skin Condition Involving Skin Barrier Impairment and Allergic Symptoms: Netherton Syndrome

Recruiting
NCT05532865

Prospective Cohort of Patients With Systemic Sclerosis at Brest University Hospital With Biobanking

Recruiting
NCT05678309

Establishment of a Patient Library in Patients With Pruritus Sine Materia

Recruiting
NCT03364296Not Applicable

Biological Dating of Cerebral Ischemia With GST-π/PRDX1 to Detect Patients With Stroke of Unknown Onset Within the Therapeutic Window of Thrombolysis

Completed
NCT05133154Not Applicable

LIQUID BIOPSY IN Low-grade Glioma Patients

Active Not Recruiting
NCT04770090Not Applicable

Research of Circulating Tumor Cells Released During Cervical Cancer Surgery

Active Not Recruiting
NCT06864481

Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis

Recruiting
NCT03976622

Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata

Enrolling By Invitation
NCT04272307Early Phase 1

MIcroorganisms as Triggers in Acute Severe Ulcerative Colitis and Their Influence on Medical Therapy Efficacy: a Multi-omics Pilot Approach.

Completed
NCT00913471

Biomarkers for Pain in Spinal Cord Injury Patients

Completed
NCT05030038

Oral Aromatase Inhibitors Modify the Gut Microbiome

Completed
NCT04067869Phase 3

Cytomegalovirus Infection in Patients With HIV-1 Infection

Completed
NCT06047106Not Applicable

Multi-parametric MRI Evaluation of Renal Graft Performance After Living Donor Donation.

Recruiting
NCT07636551Not Applicable

Baseline Assessment of Skin Resident Memory T Cells in Healthy Unvaccinated Participants

Not Yet Recruiting
NCT00401141Not Applicable

Abnormalities of B Lymphocytes During Systemic Lupus

Completed
NCT06602934Not Applicable

Long-term Alterations of Host-microbiome Interactions and Cardiovascular and Respiratory Diseases Progression After Pneumonia

Recruiting
NCT04800458Not Applicable

Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis

Recruiting

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
320